<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08056284630428</udiDi>
    <basicUdiDi>805628463MM_USM6</basicUdiDi>
    <tradeName>EDGE/H CL HI  SX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MECCANOTTICA MAZZA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000031256</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10.145.13</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T19:42:05.074Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056284630350</udiDi>
    <basicUdiDi>805628463MM_USM6</basicUdiDi>
    <tradeName>EDGE CL EL SX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MECCANOTTICA MAZZA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000031256</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10.145.01</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T19:42:04.807Z</lastUpdated>
  </row>
  <row>
    <udiDi>08056284630398</udiDi>
    <basicUdiDi>805628463MM_USM6</basicUdiDi>
    <tradeName>EDGE/H CL HI</tradeName>
    <deviceName></deviceName>
    <manufacturerName>MECCANOTTICA MAZZA S.r.l.</manufacturerName>
    <manufacturerSrn>IT-MF-000031256</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>10.140.13</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T19:42:04.740Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566195966</udiDi>
    <basicUdiDi>8436566193REFINFZ</basicUdiDi>
    <tradeName>NEO²</tradeName>
    <deviceName>Refraction Unit</deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8000405</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T11:35:46.866Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190015</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-100</tradeName>
    <deviceName>Unidad de refracción / Refraction Unit</deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42-0000208</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-03T11:35:40.463Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566195973</udiDi>
    <basicUdiDi>8436566193REFINFZ</basicUdiDi>
    <tradeName>NEO²</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8000403</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:34:42.388Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566195980</udiDi>
    <basicUdiDi>8436566193REFINFZ</basicUdiDi>
    <tradeName>NEO²</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8000424</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:34:16.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566196000</udiDi>
    <basicUdiDi>8436566193REFINFZ</basicUdiDi>
    <tradeName>NEO²</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8000495</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:34:16.678Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566196017</udiDi>
    <basicUdiDi>8436566193REFINFZ</basicUdiDi>
    <tradeName>NEO²</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>8000496</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-02T19:34:16.131Z</lastUpdated>
  </row>
  <row>
    <udiDi>08463566192749</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-600III (right finishing set white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42-0001462</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T23:40:23.482Z</lastUpdated>
  </row>
  <row>
    <udiDi>08463566192756</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-600III (left finishing set white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42-0001463</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-25T23:40:23.460Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566196833</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-600 III</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42-0004213</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:45:18.760Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566196840</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-600 III</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>42-0004214</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-22T19:45:18.297Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190749</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1D (right white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202502</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.806Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190756</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1P (right white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202503</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.787Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190763</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1 (right grey)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202504</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.769Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190770</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1D (right grey)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202506</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.752Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190787</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1P (right grey)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202507</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.735Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190794</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1 (left white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202508</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.718Z</lastUpdated>
  </row>
  <row>
    <udiDi>08436566190800</udiDi>
    <basicUdiDi>8436566193REFH6</basicUdiDi>
    <tradeName>IS-1D (left white)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ANTONI CARLES S.A.</manufacturerName>
    <manufacturerSrn>ES-MF-000001010</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Z12120119</emdnCode>
    <emdnDescription>OPHTHALMOLOGICAL TREATMENT UNITS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1202510</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-20T12:13:58.699Z</lastUpdated>
  </row>
</eudamedExport>